|
US6090382A
(en)
*
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
DK0929578T3
(da)
*
|
1996-02-09 |
2003-08-25 |
Abbott Lab Bermuda Ltd |
Humane antistoffer, der binder human TNFalfa
|
|
US7115557B2
(en)
*
|
1998-09-25 |
2006-10-03 |
Sciaticon Ab |
Use of certain drugs for treating nerve root injury
|
|
US20050226845A1
(en)
*
|
2004-03-10 |
2005-10-13 |
Chih-Ping Liu |
Method of treatment using interferon-tau
|
|
US7199102B2
(en)
*
|
2000-08-24 |
2007-04-03 |
The Regents Of The University Of California |
Orally administered peptides synergize statin activity
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
US7148197B2
(en)
*
|
2000-08-24 |
2006-12-12 |
The Regents Of The University Of California |
Orally administered small peptides synergize statin activity
|
|
US7723303B2
(en)
*
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
CA2817619A1
(en)
|
2001-06-08 |
2002-12-08 |
Abbott Laboratories (Bermuda) Ltd. |
Methods of administering anti-tnf.alpha. antibodies
|
|
US20060241074A1
(en)
*
|
2001-08-14 |
2006-10-26 |
The General Hospital Corporation |
Methods for treatment of pain
|
|
MY140561A
(en)
|
2002-02-20 |
2009-12-31 |
Nycomed Gmbh |
Dosage form containing pde 4 inhibitor as active ingredient
|
|
US20040009172A1
(en)
*
|
2002-04-26 |
2004-01-15 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
|
US9028822B2
(en)
|
2002-06-28 |
2015-05-12 |
Domantis Limited |
Antagonists against TNFR1 and methods of use therefor
|
|
US20090280065A1
(en)
*
|
2006-04-10 |
2009-11-12 |
Willian Mary K |
Uses and Compositions for Treatment of Psoriasis
|
|
US20040219142A1
(en)
|
2002-07-19 |
2004-11-04 |
Abbott Laboratories S.A. |
Treatment of skin and nail disorders using TNFalpha inhibitors
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US20050271660A1
(en)
|
2002-09-06 |
2005-12-08 |
Alexion Pharmaceuticals, Inc. |
Nebulization of monoclonal antibodies for treating pulmonary diseases
|
|
US9415102B2
(en)
|
2002-09-06 |
2016-08-16 |
Alexion Pharmaceuticals, Inc. |
High concentration formulations of anti-C5 antibodies
|
|
MY150740A
(en)
*
|
2002-10-24 |
2014-02-28 |
Abbvie Biotechnology Ltd |
Low dose methods for treating disorders in which tnf? activity is detrimental
|
|
CA2508264A1
(en)
*
|
2002-12-05 |
2004-06-24 |
Protein Design Labs, Inc. |
Methods of treatment of ulcerative colitis with anti-cd3 antibodies
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
PT1606261E
(pt)
|
2003-03-10 |
2010-01-11 |
Nycomed Gmbh |
Novo processo para a preparação de roflumilast
|
|
EP1617888B1
(en)
*
|
2003-04-23 |
2019-06-12 |
Valeritas, Inc. |
Hydraulically actuated pump for long duration medicament administration
|
|
US20040229878A1
(en)
*
|
2003-05-13 |
2004-11-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of P38 kinase
|
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
|
US8273347B2
(en)
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
|
US8361467B2
(en)
*
|
2003-07-30 |
2013-01-29 |
Depuy Spine, Inc. |
Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
|
|
CA2762015A1
(en)
|
2003-08-04 |
2005-02-24 |
Bristol-Myers Squibb Company |
Methods for treating cardiovascular disease using a soluble ctla4 molecule
|
|
US7396819B2
(en)
*
|
2003-08-08 |
2008-07-08 |
Virbac Corporation |
Anthelmintic formulations
|
|
WO2005046593A2
(en)
*
|
2003-11-06 |
2005-05-26 |
Celgene Corporation |
Methods and compositions using thalidomide for the treatment and management of cancers and other diseases.
|
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
|
WO2005094210A2
(en)
*
|
2004-03-12 |
2005-10-13 |
The Hartz Mountain Corporation |
Multi-action anthelmintic formulations
|
|
TWI439284B
(zh)
*
|
2004-04-09 |
2014-06-01 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
GB0414054D0
(en)
|
2004-06-23 |
2004-07-28 |
Owen Mumford Ltd |
Improvements relating to automatic injection devices
|
|
TWI307630B
(en)
*
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
WO2006014425A1
(en)
|
2004-07-02 |
2006-02-09 |
Biovalve Technologies, Inc. |
Methods and devices for delivering glp-1 and uses thereof
|
|
US20060046961A1
(en)
*
|
2004-09-02 |
2006-03-02 |
Mckay William F |
Controlled and directed local delivery of anti-inflammatory compositions
|
|
US20060205669A1
(en)
*
|
2004-09-16 |
2006-09-14 |
The Regents Of The University Of California |
G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
|
|
DE102004046235A1
(de)
*
|
2004-09-22 |
2006-03-30 |
Altana Pharma Ag |
Arzneimittelzubereitung
|
|
US20060083741A1
(en)
*
|
2004-10-08 |
2006-04-20 |
Hoffman Rebecca S |
Treatment of respiratory syncytial virus (RSV) infection
|
|
WO2006063132A2
(en)
|
2004-12-06 |
2006-06-15 |
The Regents Of The University Of California |
Methods for improving the structure and function of arterioles
|
|
US8663694B2
(en)
*
|
2005-03-16 |
2014-03-04 |
Takeda Gmbh |
Taste masked dosage form containing roflumilast
|
|
US7431927B2
(en)
*
|
2005-03-24 |
2008-10-07 |
Epitomics, Inc. |
TNFα-neutralizing antibodies
|
|
AU2006230419A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Targeted Genetics Corporation |
Methods for lowering the level of tumor necrosis factor (TNF) in TNF-associated disorders
|
|
US20080293639A1
(en)
*
|
2005-04-29 |
2008-11-27 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
KR20080007491A
(ko)
*
|
2005-04-29 |
2008-01-21 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
염증성 반응을 특징으로 하는 병리를 치료하기 위한 펩티드및 펩티드 모방체
|
|
CN102961746B
(zh)
|
2005-05-16 |
2016-06-15 |
艾伯维生物技术有限公司 |
TNFα抑制剂治疗腐蚀性多关节炎的用途
|
|
AU2012254978C1
(en)
*
|
2005-05-16 |
2017-06-01 |
Abbvie Biotechnology Ltd |
Use of TNF inhibitor for treatment of erosive polyarthritis
|
|
CA2610723A1
(en)
*
|
2005-06-03 |
2007-05-03 |
Biohesion, Inc. |
Gold surfaces coated with a thermostable, chemically resistant polypeptide layer and applications thereof
|
|
MX2007015476A
(es)
|
2005-06-14 |
2008-02-25 |
Amgen Inc |
Formulaciones de proteina autoamortiguadoras.
|
|
US20070041905A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
|
TWI333959B
(en)
*
|
2005-08-31 |
2010-12-01 |
Academia Sinica |
Methods and reagents for the analysis and purification of polysaccharides
|
|
US7943134B2
(en)
*
|
2005-08-31 |
2011-05-17 |
Academia Sinica |
Compositions and methods for identifying response targets and treating flavivirus infection responses
|
|
NZ567286A
(en)
*
|
2005-11-01 |
2012-03-30 |
Abbott Biotechnolgy Ltd |
Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
|
|
PL2289909T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
|
RU2432362C2
(ru)
|
2005-11-30 |
2011-10-27 |
Эбботт Лэборетриз |
Моноклональные антитела и их применения
|
|
US8795668B2
(en)
*
|
2005-12-23 |
2014-08-05 |
The Regents Of The University Of Michigan |
Methods for treating pulmonary fibrosis
|
|
CN103239773B
(zh)
|
2006-03-30 |
2015-08-26 |
瓦莱里塔斯公司 |
多筒式流体递送器械
|
|
KR20140071452A
(ko)
*
|
2006-04-05 |
2014-06-11 |
애브비 바이오테크놀로지 리미티드 |
항체 정제
|
|
US20080118496A1
(en)
*
|
2006-04-10 |
2008-05-22 |
Medich John R |
Uses and compositions for treatment of juvenile rheumatoid arthritis
|
|
EP2012824A4
(en)
*
|
2006-04-10 |
2010-06-16 |
Abbott Biotech Ltd |
USE AND COMPOSITIONS FOR THE TREATMENT OF PSORIASIS
|
|
EP2007426A4
(en)
|
2006-04-10 |
2010-06-16 |
Abbott Biotech Ltd |
COMPOSITIONS FOR THE TREATMENT OF PSORIASTIC POLYARTHRITIS AND THEIR APPLICATIONS
|
|
US9605064B2
(en)
*
|
2006-04-10 |
2017-03-28 |
Abbvie Biotechnology Ltd |
Methods and compositions for treatment of skin disorders
|
|
EP2012586A4
(en)
|
2006-04-10 |
2010-08-18 |
Abbott Biotech Ltd |
USES AND COMPOSITIONS FOR THE TREATMENT OF ANKYLOSANTE SPONDYLARTHRITIS
|
|
US20090317399A1
(en)
*
|
2006-04-10 |
2009-12-24 |
Pollack Paul F |
Uses and compositions for treatment of CROHN'S disease
|
|
US9399061B2
(en)
*
|
2006-04-10 |
2016-07-26 |
Abbvie Biotechnology Ltd |
Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis
|
|
US20080131374A1
(en)
*
|
2006-04-19 |
2008-06-05 |
Medich John R |
Uses and compositions for treatment of rheumatoid arthritis
|
|
WO2007124414A2
(en)
*
|
2006-04-21 |
2007-11-01 |
Centocor, Inc. |
Cxcl13 antagonists and their use for the treatment of inflammatory diseases
|
|
US20080311043A1
(en)
*
|
2006-06-08 |
2008-12-18 |
Hoffman Rebecca S |
Uses and compositions for treatment of psoriatic arthritis
|
|
US20100021451A1
(en)
|
2006-06-08 |
2010-01-28 |
Wong Robert L |
Uses and compositions for treatment of ankylosing spondylitis
|
|
KR101396797B1
(ko)
|
2006-06-30 |
2014-05-26 |
애브비 바이오테크놀로지 리미티드 |
자동 주사 장치
|
|
WO2008057240A2
(en)
*
|
2006-10-27 |
2008-05-15 |
Abbott Biotechnology Ltd. |
Crystalline anti-htnfalpha antibodies
|
|
US8455626B2
(en)
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
CN101200465B
(zh)
*
|
2006-12-11 |
2010-12-29 |
和记黄埔医药（上海）有限公司 |
一种十氢化萘类化合物及其医药用途
|
|
EP2124952A2
(en)
|
2007-02-27 |
2009-12-02 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
CA2681752A1
(en)
|
2007-03-29 |
2008-10-09 |
Abbott Laboratories |
Crystalline anti-human 1l-12 antibodies
|
|
US20080254011A1
(en)
*
|
2007-04-11 |
2008-10-16 |
Peter Rothschild |
Use of selected lactic acid bacteria for reducing atherosclerosis
|
|
WO2008141511A1
(fr)
*
|
2007-05-22 |
2008-11-27 |
Human Antibodomics (Shanghai) Inc. |
ANTICORPS MONOCLONAL HUMAIN ANTI-TNFα ET SON UTILISATION
|
|
EP2679996A1
(en)
*
|
2007-05-31 |
2014-01-01 |
AbbVie Inc. |
Biomarkers predictive of the responsiveness to TNF-alfa inhibitors in autoimmune disorders
|
|
EP2171451A4
(en)
*
|
2007-06-11 |
2011-12-07 |
Abbott Biotech Ltd |
METHOD FOR TREATING JUVENILIAN IDIOPATHIC ARTHRITIS
|
|
US20090110679A1
(en)
*
|
2007-07-13 |
2009-04-30 |
Luk-Chiu Li |
Methods and compositions for pulmonary administration of a TNFa inhibitor
|
|
WO2009018447A2
(en)
*
|
2007-07-31 |
2009-02-05 |
New York University |
Diagnostic and treatment methods for characterizing bacterial microbiota in skin conditions
|
|
EP2185201A4
(en)
*
|
2007-08-08 |
2011-11-30 |
Abbott Lab |
COMPOSITIONS AND METHODS FOR CRYSTALLIZING ANTIBODIES
|
|
AU2008296478B9
(en)
|
2007-08-28 |
2015-03-19 |
The Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
|
US8557767B2
(en)
|
2007-08-28 |
2013-10-15 |
Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
|
US20090098136A1
(en)
*
|
2007-10-15 |
2009-04-16 |
Alcon Research, Ltd. |
Use of tnf receptor antagonists for treating dry eye
|
|
WO2009061830A1
(en)
*
|
2007-11-06 |
2009-05-14 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
|
|
TWI543768B
(zh)
|
2007-11-30 |
2016-08-01 |
艾伯維生物技術有限責任公司 |
蛋白質調配物及製造其之方法
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
|
US20090271164A1
(en)
*
|
2008-01-03 |
2009-10-29 |
Peng Joanna Z |
Predicting long-term efficacy of a compound in the treatment of psoriasis
|
|
WO2009090189A1
(en)
|
2008-01-15 |
2009-07-23 |
Abbott Gmbh & Co.Kg |
Powdered protein compositions and methods of making same
|
|
US9365644B2
(en)
*
|
2008-04-23 |
2016-06-14 |
Epitomics, Inc. |
Anti-TNFα antibody
|
|
AU2009347206C1
(en)
*
|
2008-10-20 |
2016-12-08 |
Abbvie Inc. |
Isolation and purification of antibodies using Protein A affinity chromatography
|
|
US8722860B2
(en)
*
|
2009-04-16 |
2014-05-13 |
Abbvie Biotherapeutics Inc. |
Anti-TNF-α antibodies and their uses
|
|
KR101721906B1
(ko)
|
2009-04-29 |
2017-03-31 |
애브비 바이오테크놀로지 리미티드 |
자동 주입 장치
|
|
MX2011011772A
(es)
*
|
2009-05-04 |
2012-02-08 |
Abbott Biotech Ltd |
Formulaicones estables de anticuerpos humanos anti-tnf-alfa con alta concentracion de proteina.
|
|
NZ627052A
(en)
|
2009-12-15 |
2015-12-24 |
Abbvie Biotechnology Ltd |
Improved firing button for automatic injection device
|
|
WO2011084714A2
(en)
*
|
2009-12-17 |
2011-07-14 |
Biogen Idec Ma Inc. |
STABILIZED ANTI-TNF-ALPHA scFv MOLECULES OR ANTI-TWEAK scFv MOLECULES AND USES THEREOF
|
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
|
EP3360596A1
(en)
|
2010-04-21 |
2018-08-15 |
AbbVie Biotechnology Ltd. |
Wearable automatic injection device for controlled delivery of therapeutic agents
|
|
HRP20181598T1
(hr)
|
2010-06-03 |
2018-11-30 |
Abbvie Biotechnology Ltd |
Uporaba i pripravci za liječenje hidradenitis suppurativa (hs)
|
|
CN103298833B
(zh)
|
2010-08-14 |
2015-12-16 |
Abbvie公司 |
β淀粉样蛋白结合蛋白
|
|
SG190069A1
(en)
|
2010-11-11 |
2013-06-28 |
Abbvie Biotechnology Ltd |
IMPROVED HIGH CONCENTRATION ANTI-TNFa ANTIBODY LIQUID FORMULATIONS
|
|
MX360402B
(es)
|
2011-01-24 |
2018-10-31 |
Abbvie Biotechnology Ltd |
Dispositivos de inyeccion automaticos que tienen superficies de agarre sobremoldeadas.
|
|
WO2012121988A2
(en)
*
|
2011-03-07 |
2012-09-13 |
Celgene Corporation |
Methods for treating diseases using isoindoline compounds
|
|
KR101862291B1
(ko)
*
|
2011-04-12 |
2018-05-29 |
모레 매트릭스 인코포레이티드 |
이상 섬유모세포 증식 및 세포외 기질 침착을 특징으로 하는 질병, 질환, 또는 과정을 예방하거나 치료하기 위한 조성물 및 방법
|
|
US9890200B2
(en)
|
2011-04-12 |
2018-02-13 |
Moerae Matrix, Inc. |
Compositions and methods for preventing or treating diseases, conditions, or processes characterized by aberrant fibroblast proliferation and extracellular matrix deposition
|
|
EP2702077A2
(en)
|
2011-04-27 |
2014-03-05 |
AbbVie Inc. |
Methods for controlling the galactosylation profile of recombinantly-expressed proteins
|
|
JP5976815B2
(ja)
*
|
2011-09-23 |
2016-08-24 |
ヴェストファーリッシュ ヴィルヘルム−ユニバーシテート ミュンスター |
乾癬の治療におけるエルシニア属外部タンパク質Ｍ（ＹｏｐＭ）
|
|
US9150645B2
(en)
|
2012-04-20 |
2015-10-06 |
Abbvie, Inc. |
Cell culture methods to reduce acidic species
|
|
US9067990B2
(en)
|
2013-03-14 |
2015-06-30 |
Abbvie, Inc. |
Protein purification using displacement chromatography
|
|
WO2013158273A1
(en)
|
2012-04-20 |
2013-10-24 |
Abbvie Inc. |
Methods to modulate c-terminal lysine variant distribution
|
|
US9249182B2
(en)
|
2012-05-24 |
2016-02-02 |
Abbvie, Inc. |
Purification of antibodies using hydrophobic interaction chromatography
|
|
WO2013191352A1
(en)
|
2012-06-21 |
2013-12-27 |
Hanall Biopharma Co., Ltd. |
New uses of modified human tumor necrosis factor receptor-1 polypeptide
|
|
US9512214B2
(en)
|
2012-09-02 |
2016-12-06 |
Abbvie, Inc. |
Methods to control protein heterogeneity
|
|
HK1211981A1
(en)
|
2012-09-02 |
2016-06-03 |
Abbvie Inc. |
Methods to control protein heterogeneity
|
|
AU2013334788A1
(en)
*
|
2012-10-22 |
2015-06-04 |
Henry Ford Health Systems |
Methods for reducing risks associated with heart failure and factors associated therewith
|
|
US20140255403A1
(en)
*
|
2013-03-06 |
2014-09-11 |
Hadasit Medical Research Services & Development Ltd. |
Oral composition comprising a tnf antagonist and use thereof
|
|
SG11201507230PA
(en)
|
2013-03-12 |
2015-10-29 |
Abbvie Inc |
Human antibodies that bind human tnf-alpha and methods of preparing the same
|
|
WO2014151878A2
(en)
|
2013-03-14 |
2014-09-25 |
Abbvie Inc. |
Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
|
|
US8921526B2
(en)
|
2013-03-14 |
2014-12-30 |
Abbvie, Inc. |
Mutated anti-TNFα antibodies and methods of their use
|
|
US9017687B1
(en)
|
2013-10-18 |
2015-04-28 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same using displacement chromatography
|
|
RU2015144149A
(ru)
*
|
2013-03-15 |
2017-04-21 |
Интермьюн, Инк. |
Протеомные маркеры илф
|
|
US9827181B2
(en)
*
|
2013-06-05 |
2017-11-28 |
Industrial Technology Research Institute |
Method and pharmaceutical composition for hair growth
|
|
CN104341502B
(zh)
*
|
2013-08-09 |
2016-04-27 |
北京天成新脉生物技术有限公司 |
低免疫原性抗TNF-α全人源单抗及其应用
|
|
PL226431B1
(pl)
|
2013-08-23 |
2017-07-31 |
Inst Biochemii I Biofizyki Polskiej Akademii Nauk |
Cząsteczka miRNA do zastosowania do wytwarzania leku do zmniejszania reakcji zapalnej lub zapobiegania zwiększaniu się reakcji zapalnej organizmu
|
|
US9598667B2
(en)
|
2013-10-04 |
2017-03-21 |
Abbvie Inc. |
Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
|
|
WO2015057910A1
(en)
|
2013-10-16 |
2015-04-23 |
Oncobiologics, Inc. |
Buffer formulations for enhanced antibody stability
|
|
US9181337B2
(en)
|
2013-10-18 |
2015-11-10 |
Abbvie, Inc. |
Modulated lysine variant species compositions and methods for producing and using the same
|
|
US9085618B2
(en)
|
2013-10-18 |
2015-07-21 |
Abbvie, Inc. |
Low acidic species compositions and methods for producing and using the same
|
|
US8946395B1
(en)
|
2013-10-18 |
2015-02-03 |
Abbvie Inc. |
Purification of proteins using hydrophobic interaction chromatography
|
|
US20150139988A1
(en)
|
2013-11-15 |
2015-05-21 |
Abbvie, Inc. |
Glycoengineered binding protein compositions
|
|
CN103961694A
(zh)
*
|
2014-04-18 |
2014-08-06 |
陶惠人 |
基于p-硝基苯丙氨酸插入法构建的骨质疏松疫苗
|
|
WO2015200260A1
(en)
*
|
2014-06-24 |
2015-12-30 |
Immunomedics, Inc. |
Anti-histone therapy for vascular necrosis in severe glomerulonephritis
|
|
US10351621B2
(en)
|
2014-06-24 |
2019-07-16 |
Immunomedics, Inc. |
Anti-histone therapy in acute kidney injury
|
|
US9764122B2
(en)
|
2014-07-25 |
2017-09-19 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having an occluding member
|
|
US9775978B2
(en)
|
2014-07-25 |
2017-10-03 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
|
MX383117B
(es)
|
2014-07-31 |
2025-03-13 |
Anji Pharmaceuticals Inc |
Péptidos miméticos de la apoe y mayor potencia para depurar el colesterol en plasma.
|
|
US10112994B2
(en)
|
2014-11-05 |
2018-10-30 |
Genentech, Inc. |
Methods of producing two chain proteins in bacteria
|
|
MX382952B
(es)
|
2014-11-05 |
2025-03-13 |
Genentech Inc |
Métodos de producción de proteínas de cadena doble en bacterias.
|
|
HK1243940A1
(zh)
|
2014-11-06 |
2018-07-27 |
Scholar Rock, Inc. |
抗原肌肉生长抑制素/潜在肌肉生长抑制素的抗体及其用途
|
|
EP3227880B1
(en)
*
|
2014-12-01 |
2018-09-26 |
Truinject Corp. |
Injection training tool emitting omnidirectional light
|
|
EP3247718B1
(en)
|
2015-01-21 |
2021-09-01 |
Outlook Therapeutics, Inc. |
Modulation of charge variants in a monoclonal antibody composition
|
|
EP3679798B1
(en)
|
2015-02-03 |
2021-11-17 |
Mayo Foundation for Medical Education and Research |
Methods and materials for assessing and treating arthritis
|
|
WO2016156468A1
(en)
|
2015-03-31 |
2016-10-06 |
Vhsquared Limited |
Polypeptides
|
|
DK3277719T3
(da)
|
2015-03-31 |
2022-05-02 |
Sorriso Pharmaceuticals Inc |
Polypeptider
|
|
HK1250011A1
(zh)
|
2015-03-31 |
2018-11-23 |
Sorriso Pharmaceuticals, Inc. |
具有蛋白酶可切割接头的肽构建体
|
|
EP3078675A1
(en)
|
2015-04-10 |
2016-10-12 |
Ares Trading S.A. |
Induction dosing regimen for the treatment of tnf alpha mediated disorders
|
|
US10519207B2
(en)
|
2015-06-12 |
2019-12-31 |
Georgia State University Research Foundation, Inc. |
Compositions and methods for treating opioid tolerance
|
|
CN105175529A
(zh)
*
|
2015-07-16 |
2015-12-23 |
中国科学院海洋研究所 |
一种鱼类肿瘤坏死因子家族蛋白的重组蛋白及其应用
|
|
JP2018527903A
(ja)
*
|
2015-07-22 |
2018-09-27 |
スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． |
Ｇｄｆ１１結合タンパク質およびその使用
|
|
LT3350220T
(lt)
|
2015-09-15 |
2021-09-27 |
Scholar Rock, Inc. |
Anti pro/latentinio miostatino antikūnai ir jų panaudojimas
|
|
US10076650B2
(en)
|
2015-11-23 |
2018-09-18 |
Warsaw Orthopedic, Inc. |
Enhanced stylet for drug depot injector
|
|
CN115814077A
(zh)
|
2016-01-08 |
2023-03-21 |
供石公司 |
抗-原肌生长抑制素/潜伏肌生长抑制素抗体及其使用方法
|
|
CN109563161A
(zh)
|
2016-02-03 |
2019-04-02 |
安口生物公司 |
用于提高抗体稳定性的缓冲制剂
|
|
US10465003B2
(en)
*
|
2016-02-05 |
2019-11-05 |
Janssen Biotech, Inc. |
Anti-TNF antibodies, compositions, methods and use for the treatment or prevention of type 1 diabetes
|
|
AU2017283546C1
(en)
|
2016-06-13 |
2020-11-19 |
Scholar Rock, Inc. |
Use of myostatin inhibitors and combination therapies
|
|
US10549081B2
(en)
|
2016-06-23 |
2020-02-04 |
Warsaw Orthopedic, Inc. |
Drug delivery device and methods having a retaining member
|
|
US20190202907A1
(en)
*
|
2016-09-02 |
2019-07-04 |
180 Therapeutics Lp |
Method of treating systemic fibrotic disorders using an il-33/tnf bispecific antibody
|
|
WO2018045258A1
(en)
*
|
2016-09-02 |
2018-03-08 |
The University Of Chicago |
TREATMENT OF TNF-alpha CYTOTOXICITY
|
|
EP3519438A1
(en)
|
2016-09-30 |
2019-08-07 |
VHsquared Limited |
Compositions
|
|
AU2017345490B2
(en)
|
2016-10-21 |
2022-07-07 |
Amgen Inc. |
Pharmaceutical formulations and methods of making the same
|
|
US10434261B2
(en)
|
2016-11-08 |
2019-10-08 |
Warsaw Orthopedic, Inc. |
Drug pellet delivery system and method
|
|
EP3554342B1
(en)
|
2016-12-14 |
2024-07-24 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a tnf inhibitor
|
|
WO2018119142A1
(en)
|
2016-12-21 |
2018-06-28 |
Amgen Inc. |
Anti-tnf alpha antibody formulations
|
|
ES2944357T3
(es)
|
2017-01-06 |
2023-06-20 |
Scholar Rock Inc |
Tratamiento de enfermedades metabólicas inhibiendo la activación de miostatina
|
|
WO2018195764A1
(zh)
*
|
2017-04-25 |
2018-11-01 |
群康生技股份有限公司 |
注射笔
|
|
KR101946884B1
(ko)
*
|
2017-04-25 |
2019-02-13 |
고려대학교 산학협력단 |
대사체 분석을 이용한 베체트병의 진단방법
|
|
EP4732889A2
(en)
|
2017-06-07 |
2026-04-29 |
Supira Medical, Inc. |
Intravascular fluid movement devices, systems, and methods of use
|
|
KR20190024572A
(ko)
*
|
2017-08-30 |
2019-03-08 |
(주)셀트리온 |
TNFα 관련 질환을 치료하기 위한 피하 투여 요법
|
|
CN107362351B
(zh)
*
|
2017-09-04 |
2020-11-10 |
上海市儿童医院 |
Il-36r的拮抗剂在制备镇痛药物中的应用
|
|
JP7319266B2
(ja)
|
2017-11-13 |
2023-08-01 |
シファメド・ホールディングス・エルエルシー |
血管内流体移動デバイス、システム、および使用方法
|
|
EP4085965A1
(en)
|
2018-02-01 |
2022-11-09 |
Shifamed Holdings, LLC |
Intravascular blood pumps and methods of use and manufacture
|
|
KR20210003813A
(ko)
|
2018-04-18 |
2021-01-12 |
젠코어 인코포레이티드 |
IL-15/IL-15Rα Fc-융합 단백질 및 LAG-3 항원 결합 도메인을 함유하는 LAG-3 표적화 이종이량체 융합 단백질
|
|
CN108588040B
(zh)
*
|
2018-06-08 |
2021-06-15 |
中国医学科学院病原生物学研究所 |
重组MtMetRS、其晶体及它们在制备抗结核药物中的应用
|
|
WO2020023335A1
(en)
*
|
2018-07-25 |
2020-01-30 |
Rush University Medical Center |
Inhibition of kidney disease relapse by targeted cytokine depletion
|
|
US12161857B2
(en)
|
2018-07-31 |
2024-12-10 |
Shifamed Holdings, Llc |
Intravascular blood pumps and methods of use
|
|
WO2020073047A1
(en)
|
2018-10-05 |
2020-04-09 |
Shifamed Holdings, Llc |
Intravascular blood pumps and methods of use
|
|
EP3870050A2
(en)
*
|
2018-10-26 |
2021-09-01 |
Abbott Diabetes Care Inc. |
Methods, devices, and systems for physiological parameter analysis
|
|
CN113438961A
(zh)
|
2018-12-20 |
2021-09-24 |
Xencor股份有限公司 |
含有IL-15/IL-15Rα和NKG2D抗原结合结构域的靶向异二聚体Fc融合蛋白
|
|
CN109998488B
(zh)
*
|
2019-04-13 |
2022-08-02 |
中国医学科学院北京协和医院 |
克罗恩病和肠道溃疡型淋巴瘤的鉴别模型及构建方法
|
|
CN114364681A
(zh)
*
|
2019-05-17 |
2022-04-15 |
西建卡尔有限责任公司 |
治疗mk2介导的病症的方法
|
|
EP3983067A4
(en)
*
|
2019-06-17 |
2023-06-14 |
Mayo Foundation for Medical Education and Research |
PREVOTELLA PREPARATIONS AND TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) AND OTHER LUNG DISEASES
|
|
KR20220063148A
(ko)
|
2019-06-21 |
2022-05-17 |
소리소 파마슈티컬스 인크. |
조성물
|
|
WO2020254827A1
(en)
|
2019-06-21 |
2020-12-24 |
Vhsquared Limited |
Polypeptides
|
|
JP7680377B2
(ja)
|
2019-06-21 |
2025-05-20 |
ソリッソ ファーマシューティカルズ，インク． |
ポリペプチド
|
|
EP3996797A4
(en)
|
2019-07-12 |
2023-08-02 |
Shifamed Holdings, LLC |
INTRAVASCULAR BLOOD PUMPS AND METHOD OF USE AND METHOD OF MAKING
|
|
US11654275B2
(en)
|
2019-07-22 |
2023-05-23 |
Shifamed Holdings, Llc |
Intravascular blood pumps with struts and methods of use and manufacture
|
|
EP4010046A4
(en)
|
2019-08-07 |
2023-08-30 |
Calomeni, Michael |
Catheter blood pumps and collapsible pump housings
|
|
AU2020339737A1
(en)
|
2019-08-30 |
2022-03-17 |
Vestlandets Innovasjonsselskap As |
Method for the treatment of chronic fatigue syndrome using an inhibitory or cytotoxic agent against plasma cells
|
|
US12102815B2
(en)
|
2019-09-25 |
2024-10-01 |
Shifamed Holdings, Llc |
Catheter blood pumps and collapsible pump housings
|
|
EP4034192B1
(en)
|
2019-09-25 |
2025-12-24 |
Supira Medical, Inc. |
Intravascular blood pump systems and methods of use and control thereof
|
|
US12121713B2
(en)
|
2019-09-25 |
2024-10-22 |
Shifamed Holdings, Llc |
Catheter blood pumps and collapsible blood conduits
|
|
WO2021075535A1
(ja)
*
|
2019-10-18 |
2021-04-22 |
国立大学法人滋賀医科大学 |
異常幹細胞を標的とする糖尿病治療
|
|
EP4072650A4
(en)
|
2019-12-11 |
2024-01-10 |
Shifamed Holdings, LLC |
Descending aorta and vena cava blood pumps
|
|
WO2021127503A1
(en)
|
2019-12-19 |
2021-06-24 |
Shifamed Holdings, Llc |
Intravascular blood pumps, motors, and fluid control
|
|
TWI807338B
(zh)
*
|
2020-06-26 |
2023-07-01 |
美商美國禮來大藥廠 |
結合ＴＧＦ-α及表皮調節素（ＥＰＩＲＥＧＵＬＩＮ）之抗體於治療疼痛之用途
|
|
EP4259150A4
(en)
*
|
2020-12-09 |
2024-12-25 |
Servatus Ltd |
COMBINATION THERAPY FOR INFLAMMATORY JOINT DISEASES
|
|
AR125902A1
(es)
|
2021-05-21 |
2023-08-23 |
Lilly Co Eli |
Compuestos y métodos dirigidos a epirregulina
|
|
IL321628A
(en)
|
2022-12-22 |
2025-08-01 |
Scholar Rock Inc |
Selective and potent inhibitory antibodies for myostatin activation
|